Gilead Sciences (GILD) Earnings Analysis

Gilead Sciences (GILD) next reports earnings on 2026-08-06, consensus EPS -7.28309 USD. Last quarter (2026-05-07) it beat with EPS 2.03 USD vs 1.91 USD est (+6.3%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 17.57.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does GILD next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-7.28309 USD
Revenue estimate7.40B

GILD earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-072.03 USD1.91 USD+6.3%Beat
2025-10-302.47 USD2.13 USD+16%Beat
2025-08-072.01 USD1.96 USD+2.6%Beat
2025-04-241.81 USD1.78 USD+1.7%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

GILD valuation and analyst view

Trailing P/E17.57
Trailing EPS7.42 USD
Price / book6.88
Dividend yield2.47%
Market cap163.09B
Analyst consensusBuy (40 buy / 17 hold / 1 sell)
Avg price target147.5 USD

Related research pages

Frequently asked questions

When is Gilead Sciences (GILD)'s next earnings date?

Gilead Sciences is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -7.28309 USD and revenue estimate of 7.40B.

Did GILD beat earnings last quarter?

In its 2026-05-07 report, GILD posted EPS of 2.03 USD versus a 1.91 USD estimate — a beat of 6.3%.

What is GILD's earnings track record?

Over the last 4 reported quarters with consensus data, GILD beat estimates 4 times (100%).

What is GILD's current P/E ratio and EPS?

GILD trades at a trailing P/E of 17.57 on trailing EPS of 7.420289855072464 USD.

What do analysts rate GILD?

Analyst consensus is "Buy" across 58 ratings (0 strong buy, 40 buy, 17 hold, 1 sell, 0 strong sell). Average 12-month price target: 147.5 USD.